Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, ...

Background—The inhaled anesthetic sevoflurane has been demonstrated to protect against myocardial ischemia/reperfusion (MI/R) injury via mechanisms involving AMP-activated protein kinase (AMPK) and ...